A comprehensive review of interventions in the NOD mouse and implications for translation.

[1]  Michel Goldman,et al.  Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. , 2005, The New England journal of medicine.

[2]  D. Harlan,et al.  A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes , 2005, Diabetes.

[3]  J. Krischer,et al.  Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1. , 2005, Diabetes care.

[4]  M. Atkinson,et al.  Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes , 2004, Nature Reviews Immunology.

[5]  P. Pozzilli,et al.  Cytokine profile and insulin antibody IgG subclasses in patients with recent onset Type 1 diabetes treated with oral insulin , 2004, Diabetologia.

[6]  E. Bonifacio,et al.  Pancreatic β-Cell Function and Immune Responses to Insulin After Administration of Intranasal Insulin to Humans At Risk for Type 1 Diabetes , 2004 .

[7]  Q. Mi,et al.  Perturbed Homeostasis of Peripheral T Cells Elicits Decreased Susceptibility to Anti-CD3-Induced Apoptosis in Prediabetic Nonobese Diabetic Mice1 , 2004, The Journal of Immunology.

[8]  G. Szot,et al.  Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. , 2004, The Journal of clinical investigation.

[9]  Linrong Lu,et al.  Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Jeffrey A. Bluestone,et al.  In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.

[11]  R. Hetzer,et al.  ROLE OF THE THYMUS IN TRANSPLANTATION TOLERANCE IN MINIATURE SWINE: IV. THE THYMUS IS REQUIRED DURING THE INDUCTION PHASE, BUT NOT THE MAINTENANCE PHASE, OF RENAL ALLOGRAFT TOLERANCE1 , 2004, Transplantation.

[12]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.

[13]  M. Fujimiya,et al.  Extrapancreatic insulin-producing cells in multiple organs in diabetes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Bluestone,et al.  Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells 1 , 2003, The Journal of Immunology.

[15]  T. Flotte,et al.  Systemic Overexpression of IL-10 Induces CD4+CD25+ Cell Populations In Vivo and Ameliorates Type 1 Diabetes in Nonobese Diabetic Mice in a Dose-Dependent Fashion 1 , 2003, The Journal of Immunology.

[16]  J. Bluestone,et al.  TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes , 2003, Nature Medicine.

[17]  S. Khoury,et al.  The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice , 2003, The Journal of experimental medicine.

[18]  J. Lohr,et al.  The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens , 2003, Nature Immunology.

[19]  A. Cooke,et al.  Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes , 2003, European journal of immunology.

[20]  H. Mcdevitt,et al.  Tumor necrosis factor-α regulation of CD4+C25+ T cell levels in NOD mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Wu,et al.  The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice , 2002, Diabetologia.

[22]  Meng Chen,et al.  Suppression of Autoimmune Diabetes by Viral IL-10 Gene Transfer1 , 2002, The Journal of Immunology.

[23]  P. Mottram,et al.  Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies. , 2002, Transplant immunology.

[24]  D. Harlan,et al.  Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. , 2002, The New England journal of medicine.

[25]  D. Scott,et al.  Gene Transfer of Ig-Fusion Proteins Into B Cells Prevents and Treats Autoimmune Diseases1 , 2002, The Journal of Immunology.

[26]  T. Flotte,et al.  Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Stephen S. Wilson,et al.  Therapeutic Alteration of Insulin-Dependent Diabetes Mellitus Progression by T Cell Tolerance to Glutamic Acid Decarboxylase 65 Peptides In Vitro and In Vivo1 , 2001, The Journal of Immunology.

[28]  H. Weiner,et al.  Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. , 2001, International immunology.

[29]  W. Cefalu,et al.  Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study , 2001, The Lancet.

[30]  A. Isacchi,et al.  Early Th1 Response in Unprimed Nonobese Diabetic Mice to the Tyrosine Phosphatase-Like Insulinoma-Associated Protein 2, an Autoantigen in Type 1 Diabetes , 2000, The Journal of Immunology.

[31]  E. Niki,et al.  Prevention of Type I Diabetes by Low-Dose Gamma Irradiation in NOD Mice , 2000, Radiation research.

[32]  M. Kasuga,et al.  Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice. , 2000, Diabetes.

[33]  M. Cameron,et al.  Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer , 2000, Gene Therapy.

[34]  C. Boitard,et al.  Oral insulin administration and residual (β-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial , 2000, The Lancet.

[35]  A. T. N. Group,et al.  No effect of oral insulin on residual beta-cell function in recent-onset Type I diabetes (the IMDIAB VII) , 2000, Diabetologia.

[36]  J. Bluestone,et al.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.

[37]  K. Haskins,et al.  Induction of Diabetes in Nonobese Diabetic Mice by Th2 T Cell Clones from a TCR Transgenic Mouse1 , 2000, The Journal of Immunology.

[38]  A. Rosenbloom.  Prevention of Type 1 Diabetes: Perspectives , 2000 .

[39]  J. Krischer,et al.  Therapeutic controversy: prevention and treatment of diabetes in children. , 2000 .

[40]  F. Nicoletti,et al.  Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice. , 1999, Diabetes.

[41]  G. Prud’homme,et al.  Intramuscular administration of expression plasmids encoding interferon‐γ receptor/IgG1 or IL‐4/IgG1 chimeric proteins protects from autoimmunity , 1999, The journal of gene medicine.

[42]  I Mahmood,et al.  Allometric issues in drug development. , 1999, Journal of pharmaceutical sciences.

[43]  J. Petersen,et al.  Insulin in oral immune "tolerance": a one-amino acid change in the B chain makes the difference. , 1999, Journal of immunology.

[44]  S. W. Kim,et al.  Anti-GAD Monoclonal Antibody Delays the Onset of Diabetes Mellitus in NOD Mice , 1999, Pharmaceutical Research.

[45]  Meroni,et al.  Endogenous interleukin‐12 only plays a key pathogenetic role in non‐obese diabetic mouse diabetes during the very early stages of the disease , 1999, Immunology.

[46]  Onji,et al.  Transfer of dendritic cells (DC) ex vivo stimulated with interferon‐gamma (IFN‐γ) down‐modulates autoimmune diabetes in non‐obese diabetic (NOD) mice , 1999, Clinical and experimental immunology.

[47]  J. Miyazaki,et al.  Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice. , 1998, Human gene therapy.

[48]  K. Buschard,et al.  Effect of intrathymic administration of mycobacterial heat shock protein 65 and peptide p277 on the development of diabetes in NOD mice: caution required in vaccination studies , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[49]  M. Kasuga,et al.  Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice. , 1998, Clinical immunology and immunopathology.

[50]  M. Atkinson,et al.  Retardation or Acceleration of Diabetes in NOD/Lt Mice Mediated by Intrathymic Administration of Candidate β-Cell Antigens , 1997, Diabetes.

[51]  Bhagirath Singh,et al.  The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. , 1997, Immunity.

[52]  R. Tisch,et al.  CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. , 1997, Journal of immunology.

[53]  D. Cohen,et al.  Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice. , 1997, The Journal of clinical investigation.

[54]  L. Adorini,et al.  Deviation of pancreas‐infiltrating cells to Th2 by interleukin‐12 antagonist administration inhibits autoimmune diabetes , 1997, European journal of immunology.

[55]  Y. W. Kim,et al.  Inhibition of diabetes in non-obese diabetic mice by nicotinamide treatment for 5 weeks at the early age. , 1997, Journal of Korean medical science.

[56]  T. Maki,et al.  Regulation of autoimmune diabetes by interleukin 3-dependent bone marrow-derived cells in NOD mice. , 1997, Journal of autoimmunity.

[57]  M. Kurrer,et al.  T Helper 2 (Th2) T Cells Induce Acute Pancreatitis and Diabetes in Immune-compromised Nonobese Diabetic (NOD) Mice , 1997, The Journal of experimental medicine.

[58]  C. Peterson,et al.  Dapsone Decreases the Cumulative Incidence of Diabetes in Non-Obese Diabetic Female Mice , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[59]  H. Kolb,et al.  Oral insulin for diabetes prevention in NOD mice: potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant , 1997, Diabetologia.

[60]  P. Nickerson,et al.  A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. , 1997, Journal of immunology.

[61]  J. Petersen,et al.  A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[62]  L. Chatenoud,et al.  CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. , 1997, Journal of immunology.

[63]  L. Harrison,et al.  Aerosol Insulin Induces Regulatory CD8 γδ T Cells That Prevent Murine Insulin-dependent Diabetes , 1996, The Journal of experimental medicine.

[64]  S. Henderson,et al.  Prevention of a Thl Disease by a Thl, Cytokine: IL‐12 and Diabetes in, NOD Mice , 1996 .

[65]  H. Jun,et al.  A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. , 1996, Journal of autoimmunity.

[66]  J. Peterson,et al.  Transfer of Diabetes in the NOD-scid Mouse by CD4 T-Cell Clones: Differential Requirement for CD8 T-Cells , 1996, Diabetes.

[67]  C. Thivolet,et al.  Active Suppression of Diabetes after Oral Administration of Insulin Is Determined by Antigen Dosage , 1996, Annals of the New York Academy of Sciences.

[68]  H. Weiner,et al.  Oral Insulin Does Not Prevent Insulin‐dependent Diabetes Melltus in BB Rats , 1996, Annals of the New York Academy of Sciences.

[69]  K. Amano,et al.  Administration of monoclonal antibodies against vascular cell adhesion molecule-1/very late antigen-4 abrogates predisposing autoimmune diabetes in NOD mice. , 1995, Cellular immunology.

[70]  J. Ferrara,et al.  CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice , 1995, The Journal of experimental medicine.

[71]  A. Cooke,et al.  In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. , 1995, The Journal of clinical investigation.

[72]  C Benoist,et al.  T helper cell subsets in insulin-dependent diabetes. , 1995, Science.

[73]  J. Bluestone,et al.  Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse , 1995, The Journal of experimental medicine.

[74]  J. Krischer,et al.  Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. , 1995, The Journal of clinical investigation.

[75]  L. Adorini,et al.  Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice , 1995, The Journal of experimental medicine.

[76]  R. Tisch,et al.  Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process , 1994, The Journal of experimental medicine.

[77]  M. Monahan,et al.  Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. , 1994, Clinical immunology and immunopathology.

[78]  L. Chatenoud,et al.  Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[79]  A. Signore,et al.  Tolbutamide reduces the incidence of diabetes mellitus, but not insulitis, in the non-obese-diabetic mouse , 1993, Diabetologia.

[80]  J. Sredy,et al.  Rapamycin prevents the onset of insulin‐dependent diabetes mellitus (IDDM) in NOD mice , 1992, Clinical and experimental immunology.

[81]  G. Soma,et al.  Homeostasis as regulated by activated macrophage. V. Suppression of diabetes mellitus in non-obese diabetic mice by LPSw (a lipopolysaccharide from wheat flour). , 1992, Chemical & pharmaceutical bulletin.

[82]  T. Maki,et al.  Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[83]  A. Hayward,et al.  Reduced incidence of insulitis in NOD mice following anti-CD3 injection: requirement for neonatal injection. , 1992, Journal of autoimmunity.

[84]  J. Satoh,et al.  Inhibition of autoimmune diabetes in NOD mice with serum from streptococcal preparation (OK‐432)‐injected mice , 1991, Clinical and experimental immunology.

[85]  H. Weiner,et al.  Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. , 1991 .

[86]  M. Matsumoto,et al.  Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouse. II. Suppression of pathogenesis by macrophage transfer from BCG-vaccinated mice. , 1991, Cellular immunology.

[87]  P. Bedossa,et al.  CD8+ T cell homing to the pancreas in the nonobese diabetic mouse is CD4+ T cell-dependent. , 1991, Journal of immunology.

[88]  R. Elliott,et al.  Early nicotinamide treatment in the NOD mouse: effects on diabetes and insulitis suppression and autoantibody levels. , 1990, Diabetes research.

[89]  K. Haskins,et al.  Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. , 1990, Science.

[90]  M. Atkinson,et al.  Insulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy , 1990, Diabetes.

[91]  H. Mcdevitt,et al.  Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[92]  J. Satoh,et al.  Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice. , 1989, The Journal of clinical investigation.

[93]  A. Hayward,et al.  Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes. , 1989, Journal of immunology.

[94]  C. Fathman,et al.  Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. , 1988, Science.

[95]  C. Boitard,et al.  Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells , 1987, The Journal of experimental medicine.

[96]  M. Suko,et al.  Preventive effects of Cyclosporin on diabetes in NOD mice , 1986, Diabetologia.

[97]  T. Hanafusa,et al.  Preventive and Therapeutic Effects of Large-Dose Nicotinamide Injections on Diabetes Associated with Insulitis: An Observation in Nonobese Diabetic (NOD) Mice , 1982, Diabetes.

[98]  Y. Tochino,et al.  Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.

[99]  Mark S. Anderson,et al.  The NOD mouse: a model of immune dysregulation. , 2005, Annual review of immunology.

[100]  D. Greiner,et al.  Rat models of type 1 diabetes: genetics, environment, and autoimmunity. , 2004, ILAR journal.

[101]  M. Atkinson,et al.  Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice , 2004, Gene Therapy.

[102]  Simon C Watkins,et al.  Dendritic cells transduced to express interleukin-4 prevent diabetes in nonobese diabetic mice with advanced insulitis. , 2003, Human gene therapy.

[103]  Peter Lipsky,et al.  Cytokines and autoimmunity , 2002, Nature Reviews Immunology.

[104]  J. Bluestone,et al.  Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. , 2001, Annual review of immunology.

[105]  L. Chatenoud,et al.  Tolerance to islet autoantigens in type 1 diabetes. , 2001, Annual review of immunology.

[106]  N. Maclaren,et al.  Effect of oral and intravenous insulin and glutamic acid decarboxylase in NOD mice. , 1997, Autoimmunity.

[107]  J. B. Classen,et al.  The timing of immunization affects the development of diabetes in rodents. , 1996, Autoimmunity.

[108]  A. Signore,et al.  Standardizing experiments with NOD mice. , 1996, Autoimmunity.

[109]  L. Chatenoud,et al.  [Remission of established disease in diabetic NOD mice induced by anti-CD3 monoclonal antibody]. , 1992, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[110]  N. Doll,et al.  High dose nicotinamide fails to prevent diabetes in BB rats. , 1989, Autoimmunity.